Dynatronics Co. (NASDAQ:DYNT) has received an average broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.

Brokers have set a 1-year consensus price objective of $7.50 for the company, according to Zacks. Zacks has also assigned Dynatronics an industry rank of 80 out of 255 based on the ratings given to its competitors.

Several equities research analysts have issued reports on DYNT shares. Zacks Investment Research lowered shares of Dynatronics from a “buy” rating to a “hold” rating in a research report on Wednesday, July 25th. ValuEngine upgraded shares of Dynatronics from a “hold” rating to a “buy” rating in a research report on Thursday, August 2nd. Finally, TheStreet upgraded shares of Dynatronics from a “d” rating to a “c-” rating in a research report on Thursday, September 27th.

Shares of DYNT stock traded down $0.19 during trading hours on Wednesday, reaching $2.80. The stock had a trading volume of 4,100 shares, compared to its average volume of 9,425. The company has a current ratio of 1.47, a quick ratio of 0.72 and a debt-to-equity ratio of 0.34. Dynatronics has a 12 month low of $2.15 and a 12 month high of $3.60. The firm has a market capitalization of $23.26 million, a P/E ratio of -6.95 and a beta of -0.15.

Dynatronics (NASDAQ:DYNT) last released its quarterly earnings data on Thursday, September 27th. The medical equipment provider reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.01). Dynatronics had a negative net margin of 2.49% and a negative return on equity of 8.09%. The firm had revenue of $16.90 million during the quarter. Sell-side analysts predict that Dynatronics will post -0.06 EPS for the current year.

About Dynatronics

Dynatronics Corporation designs, manufactures, distributes, and markets physical medicine products in the United States and internationally. It manufactures and sells electrotherapy, therapeutic ultrasound, phototherapy, thermal therapy, iontophoresis devices, and other modalities; traction therapy equipment; and medical supplies and soft goods, including hot and cold packs, lumbar rolls, exercise balls, wrist splints, ankle weights, cervical collars and pillows, slings, bolsters, positioning wedges, back cushions, weight racks, rehabilitation products, back and wrist braces.

Read More: Why do companies issue stock splits?

Get a free copy of the Zacks research report on Dynatronics (DYNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.